1、For immediate release 2.0%3.0%/2.5%2.0%3.0%/2.5%$91.6B$92.4B/$92.0B 3.3%4.3%/3.8%$90.9B$91.7B/$91.3B 2.5%3.5%/3.0%$91.0B$91.8B/$91.4B 2.6%3.6%/3.1%$89.2B$90.0B/$89.6B 0.5%1.5%/1.0%$10.50$10.70/$10.60 5.2%7.2%/6.2%$10.75$10.95/$10.85 7.7%9.7%/8.7%$10.50$10.70/$10.60 5.2%7.2%/6.2%$10.50$10.70/$10.60 5

2、.2%7.2%/6.2%Johnson&Johnson and SubsidiariesSupplementary Sales Data(Unaudited;Dollars in Millions)20252024TotalOperationsCurrencySales to customers bysegment of businessInnovative Medicine U.S.8,092$7,612 6.3%6.3 -International5,781 5,950 (2.9)1.5 (4.4)13,873 13,562 2.3 4.2 (1.9)MedTech U.S.4,213 4

3、,008 5.1 5.1 -International3,807 3,813 (0.2)3.0 (3.2)8,020 7,821 2.5 4.1 (1.6)U.S.12,305 11,620 5.9 5.9 -International9,588 9,763 (1.8)2.1 (3.9)Worldwide21,893$21,383 2.4%4.2 (1.8)Note:Percentages have been calculated using actual,non-rounded figures and,therefore,may not recalculate precisely.FIRST

4、 QUARTER Percent ChangeJohnson&Johnson and SubsidiariesSupplementary Sales Data(Unaudited;Dollars in Millions)20252024TotalOperationsCurrencySales to customers bygeographic areaU.S.12,305$11,620 5.9%5.9 -Europe5,110 5,163 (1.0)2.2 (3.2)Western Hemisphere excluding U.S.1,167 1,194 (2.3)9.2 (11.5)Asia

5、-Pacific,Africa3,311 3,406 (2.8)(0.6)(2.2)International9,588 9,763 (1.8)2.1 (3.9)Worldwide21,893$21,383 2.4%4.2 (1.8)Note:Percentages have been calculated using actual,non-rounded figures and,therefore,may not recalculate precisely.FIRST QUARTERPercent ChangeJohnson&Johnson and Subsidiaries Condense

6、d Consolidated Statement of Earnings (Unaudited;in Millions Except Per Share Figures)PercentPercentPercentIncreaseAmountto SalesAmountto Sales(Decrease)Sales to customers21,893$100.0 21,383$100.0 2.4Cost of products sold7,357 33.6 6,511 30.4 13.0Gross Profit14,536 66.4 14,872 69.6 (2.3)Selling,marke